The results showed that the SOFA scores of the drug treatment groups on the 7th day were significantly lower than those of the baseline, especially in the high-dose group, where the decrease was ...

Specialists are debating the best approach in cardiogenic shock after a new analysis of data comparing Impella with ...

In recent years, healthcare has witnessed a shift from traditional decision-making systems to more dynamic, real-time solutions powered by artificial intelligence and advanced analytics. Satya Manesh ...

Late-Breaking scientific poster at the American Thoracic Society Advances in Pulmonary Vascular Disease sessions will present AV-001 activity in SARS-CoV-2 Infection/COVID-19 ...

The 21st Emirates Critical Care Conference commenced Friday at the InterContinental Festival City Hotel in Dubai, held in parallel with the 2nd World Summit of the World Federation of Intensive and ...

This experience was particularly traumatic for Weber, who previously lost a son to Sudden Infant Death Syndrome (SIDS) in ...

Elisabeth Weber used to attend abortion protests, standing outside clinics and waving a placard as patients filed inside. But ...

In this single-arm trial, the median overall survival (OS) observed was 4.0 months (95% CI: 2.5-7.2) among all 64 adults in the primary efficacy analysis based on the Kaplan-Meier estimate. The median ...

A Camilla woman who lost both of her legs was awarded a $70 million settlement in a medical malpractive lawsuit.

Several key events are taking place across Belfast over the next fortnight to raise awareness around ME (Myalgic ...

Patients who are immunocompromised still can receive a variety of vaccinations based on their specific needs, Cassandra ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , and Alvotech today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDItm (ustekinumab-aekn) ...